Cellosaurus TTNT-16-3 (CVCL_B6EQ)
Cell line name | TTNT-16-3 | |
---|---|---|
Synonyms | 16-T3 | |
Accession | CVCL_B6EQ | |
Resource Identification Initiative | To cite this cell line use: TTNT-16-3 (RRID:CVCL_B6EQ) | |
Comments | Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the TERT gene. Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites and a plasmid pCAGMerCreMer/Puro that expresses Cre fused to 2 mutant estrogen-receptor ligand-binding domains (MerCreMer) under the control of the CAG promoter. Doubling time: ~48 hours (PubMed=17434229). Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT. Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre. Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: In situ; Liver; UBERON=UBERON_0002107. Cell type: Hepatocyte; CL=CL_0000182. | |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
Hierarchy | Parent: CVCL_B6EN (TTNT-16) Children:
| |
Sex of cell | Sex unspecified | |
Age at sampling | Age unspecified | |
Category | Telomerase immortalized cell line | |
Publications | PubMed=14693704; DOI=10.2337/diabetes.53.1.105 PubMed=17434229; DOI=10.1016/j.jhep.2007.02.019 | |
Cross-references | ||
Encyclopedic resources | Wikidata; Q112041867 | |
Entry history | ||
Entry creation | 17-Mar-2022 | |
Last entry update | 10-Apr-2025 | |
Version number | 7 |